This review analyzes benzothiazole derivatives' roles in drug discovery and highlights their therapeutic potential.
Benzothiazole, a privileged heterocyclic scaffold, has firmly established itself as a cornerstone in medicinal chemistry due to its remarkable pharmacological versatility and drug-like properties. This review provides a comprehensive analysis of the therapeutic significance of benzothiazole derivatives, delving into their synthetic methodologies and expansive biological profile. The core structure, a fusion of benzene and thiazole rings, confers a unique electronic configuration that facilitates diverse interactions with critical biological targets. This molecular adaptability translates into a wide spectrum of potent therapeutic activities. Notably, benzothiazole-based compounds have demonstrated significant efficacy as anticancer agents by inducing apoptosis and inhibiting proliferation, as antimicrobials capable of combating resistant pathogens, and as anti-inflammatory agents that modulate key enzymatic pathways. Furthermore, their promising roles in managing neurological disorders, diabetes, tuberculosis, and oxidative stress-related conditions are extensively explored. The discussion encompasses structure-activity relationships that guide the rational design of novel analogues, highlighting how strategic substitutions enhance potency, selectivity, and pharmacokinetic profiles. This review not only consolidates recent advancements but also underscores the immense potential of the benzothiazole nucleus as a robust platform for developing new therapeutic agents to address unmet medical needs across various disease domains, thereby serving as an invaluable resource for researchers in drug discovery.
No takes yet. Share an insight, caveat, or question.
Rahate et al. (2025) studied this question.